These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
136 related items for PubMed ID: 3136635
1. Flecainide for supraventricular tachycardia in children. Zeigler V, Gillette PC, Hammill B, Ross BA, Ewing L. Am J Cardiol; 1988 Aug 25; 62(6):41D-43D. PubMed ID: 3136635 [Abstract] [Full Text] [Related]
2. Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia. Hellestrand KJ. Am J Cardiol; 1996 Jan 25; 77(3):83A-88A. PubMed ID: 8607396 [Abstract] [Full Text] [Related]
3. Intravenous flecainide acetate for supraventricular tachycardias. Hellestrand KJ. Am J Cardiol; 1988 Aug 25; 62(6):16D-22D. PubMed ID: 3136630 [Abstract] [Full Text] [Related]
4. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group. Hopson JR, Buxton AE, Rinkenberger RL, Nademanee K, Heilman JM, Kienzle MG. Am J Cardiol; 1996 Jan 25; 77(3):72A-82A. PubMed ID: 8607395 [Abstract] [Full Text] [Related]
5. Flecainide acetate for conversion of acute supraventricular tachycardia to sinus rhythm. Crozier IG, Ikram H, Kenealy M, Levy L. Am J Cardiol; 1987 Mar 01; 59(6):607-9. PubMed ID: 3103410 [Abstract] [Full Text] [Related]
6. Efficacy and safety of class IC antiarrhythmic agents for the treatment of coexisting supraventricular and ventricular tachycardia. Rinkenberger RL, Naccarelli GV, Berns E, Dougherty AH. Am J Cardiol; 1988 Aug 25; 62(6):44D-55D. PubMed ID: 3136636 [Abstract] [Full Text] [Related]
7. [Treatment of recurrent supraventricular tachyarrhythmias with flecainide or a flecainide and amiodarone combination]. Purcaro A, Capestro F, Ciampani N, Fratadocchi GB, Mazzanti M, Costantini C, Molini E. G Ital Cardiol; 1987 Aug 25; 17(8):690-8. PubMed ID: 3121426 [Abstract] [Full Text] [Related]
8. Electrophysiologic effects and clinical efficacy of flecainide in children with recurrent paroxysmal supraventricular tachycardia. Musto B, D'Onofrio A, Cavallaro C, Musto A, Greco R. Am J Cardiol; 1988 Aug 01; 62(4):229-33. PubMed ID: 3135739 [Abstract] [Full Text] [Related]
9. Electrophysiologic effects and therapeutic efficacy of intravenous flecainide for termination of paroxysmal supraventricular tachycardia. Gambhir DS, Bhargava M, Arora R, Khalilullah M. Indian Heart J; 1995 Aug 01; 47(3):237-43. PubMed ID: 7558090 [Abstract] [Full Text] [Related]
10. Long-term efficacy and safety of flecainide for supraventricular tachycardia. Neuss H, Schlepper M. Am J Cardiol; 1988 Aug 25; 62(6):56D-61D. PubMed ID: 3136637 [Abstract] [Full Text] [Related]
11. [Effects of intravenous flecainide acetate in patients with concealed atrioventricular pathway with supraventricular tachycardia]. Song Y. Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Dec 25; 19(6):361-3, 397. PubMed ID: 1821351 [Abstract] [Full Text] [Related]
12. Flecainide therapy in patients treated for supraventricular tachycardia with near normal left ventricular function. Hughes MM, Trohman RG, Simmons TW, Castle LW, Wilkoff BL, Morant VA, Maloney JD. Am Heart J; 1992 Feb 25; 123(2):408-12. PubMed ID: 1736577 [Abstract] [Full Text] [Related]
13. Summary of efficacy and safety of flecainide for supraventricular arrhythmias. Anderson JL, Jolivette DM, Fredell PA. Am J Cardiol; 1988 Aug 25; 62(6):62D-66D. PubMed ID: 3136638 [Abstract] [Full Text] [Related]
14. Treatment of refractory supraventricular arrhythmias with flecainide acetate. Till JA, Rowland E, Shinebourne EA, Ward DE. Arch Dis Child; 1987 Mar 25; 62(3):247-52. PubMed ID: 3105471 [Abstract] [Full Text] [Related]
15. Rapid control of foetal supraventricular tachycardia with digoxin and flecainide combination treatment. Uzun O, Babaoglu K, Sinha A, Massias S, Beattie B. Cardiol Young; 2012 Aug 25; 22(4):372-80. PubMed ID: 22008551 [Abstract] [Full Text] [Related]
16. Flecainide acetate in the treatment of supraventricular tachycardias: value of programmed electrical stimulation for long-term prognosis. van Wijk LM, Crijns HJ, van Gilst WH, Wesseling H, Lie KI. Am Heart J; 1989 Feb 25; 117(2):365-9. PubMed ID: 2492738 [Abstract] [Full Text] [Related]
17. A comparison of oral flecainide and amiodarone for the treatment of recurrent supraventricular tachycardia in children. Hill AC, Silka MJ, Bar-Cohen Y. Pacing Clin Electrophysiol; 2019 Jun 25; 42(6):670-677. PubMed ID: 30875081 [Abstract] [Full Text] [Related]
18. Flecainide as first-line treatment for supraventricular tachycardia in newborns. Ferlini M, Colli AM, Bonanomi C, Salvini L, Galli MA, Salice P, Ravaglia R, Centola M, Danzi GB. J Cardiovasc Med (Hagerstown); 2009 May 25; 10(5):372-5. PubMed ID: 19300276 [Abstract] [Full Text] [Related]
19. Short- and long-term efficacy and safety of flecainide acetate for supraventricular arrhythmias. Hohnloser SH, Zabel M. Am J Cardiol; 1992 Aug 20; 70(5):3A-9A; discussion 9A-10A. PubMed ID: 1387287 [Abstract] [Full Text] [Related]
20. Long-term follow-up of patients with inducible supraventricular tachycardia treated with flecainide or propafenone: therapy guided by transesophageal electropharmacologic testing. Furlanello F, Guarnerio M, Inama G, Vergara G, Del Greco M, Bertoldi A, Dallago M. Am J Cardiol; 1992 Aug 20; 70(5):19A-25A. PubMed ID: 1509994 [Abstract] [Full Text] [Related] Page: [Next] [New Search]